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justiﬁed. CONCLUSIONS: Knowledge in pharmacoeconomics
among pharmacists may lead to a deeper engagement of this
group of professionals in a more appropriate management of
drugs.
PHP21
QUALITY ASSESSMENT OF AN AMBULATORY CARE CLINIC
BASED COLLABORATIVE CARE APPROACH FOR ACHIEVING
THERAPEUTIC GOALS
Brown LM1, Isetts B2
1University of Tennessee, Memphis,TN, USA; 2University of
Minnesota, Minneapolis, MN, USA
OBJECTIVES: The objectives of this study were to: 1) assess the
quality of patient care provided by 6 Medication Therapy Man-
agement (MTM) pharmacists who were working collaboratively
with physicians in 6 ambulatory care clinics in the Minneapolis,
MN metropolitan area; and 2) determine the MTM pharmacists’
ability to identify and resolve drug therapy problems.
METHODS: The quality of therapeutic determinations made by
pharmacists within this collaborative practice of MTM was
studied using a 9-member panel of physicians (6) and pharma-
cists (3). The panel reviewed the care provided to nine randomly
selected patient records from the 286 MTM patients who were
Blue Cross/Blue Shield Blue Plus members. A structured implicit
review process was used by the reviewers to specify their level of
agreement with the therapeutic decisions made by the MTM
pharmacists. The reviewers used a 7-point Likert scale to 
specify their level of agreement with each therapeutic decision.
RESULTS: There were 6444 therapeutic review determinations
made by the review panel. The 9 reviewers expressed agreement
with 90.7% of the decisions. They expressed disagreement with
only 2.8% of the decisions. For each therapeutic decision, two-
thirds or more of the reviewers agreed with the decision made
in 99.9% of the cases. There was no difference in the mean
ratings of the 9 patients based on an ANOVA (p = 0.906).
Regarding drug therapy problems (DTP’s), there were 20 DTP’s
identiﬁed during the initial patient visits. All but 5 DTP’s were
resolved by the second visit. CONCLUSIONS: The decisions
made by MTM practitioners working in collaboration with
physicians are clinically credible based on the ratings and com-
ments of a peer review panel. This study provides information
on the quality of care provided by pharmacists in the collabora-
tive practice of medication therapy management.
PHP22
MEDICATION AND SOCIO-ECONOMIC STATUS IN A
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OBJECTIVES: Presently, statements on associations of socioe-
conomic status (SES) and use of medication are based on few
and contradictory empirical data. Within the framework of the
ongoing Heinz Nixdorf Recall study (HNRS), we can examine
medication use and SES in detail. METHODS: The HNRS is a
population-based cohort study to assess the predictive value of
new risk factors for coronary artery disease. A random sample
of 4518 men and women aged 45–74 years was recruited from
the German cities of Bochum, Essen, and Mülheim between
2000–2003. We assessed the seven-day prevalence of any 
medication-use from 4519 subjects. Age, gender, highest school
degree, highest professional training and income served as deter-
minants of medication prevalence. Logistic regressions were used
to estimate multivariate associations. RESULTS: A total of
11,500 drugs were taken by 3449 (76%) subjects, with ACE-
inhibitors (9%), beta-blockers (8%), sexual hormones (6%), and
statins (5%) ranked ﬁrst. As expected, the prevalence of drug use
increased with age, women reported a higher use than men (83
vs. 70%). For participants with the lowest compared to partici-
pants with the highest professional training an odds ratio (OR)
of 2.04 (95% CI: 1.60–2.60) for taking medication was calcu-
lated. Adjusted for age and gender, this signiﬁcant difference
between social classes disappeared. Otherwise, gender speciﬁc
analyses showed an age-adjusted OR for women with the lowest
educational level of 2.0 (1.31–3.05) compared to women with
the highest educational level and for men a higher use of psy-
chopharmaceutics in the lowest compared the highest income
group (1.92; 1.02–5.05). CONCLUSIONS: The association of
SES on drug use is still not clear and seems to alter with the con-
struct of social status, gender and drug groups. In particular, the
challenging task to differentiate between the inﬂuence capability
of SES on medication, medication on health/disease and vice
versa has to be considered.
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ANALYSIS OF CLINICAL INTERVENTION DOCUMENTATION
BY PHARMACISTS
Steimle T, Meier K, Melzer S
LBK Hamburg, Hamburg, Germany
OBJECTIVES: At LBK Hamburg, pharmacists started 1995 with
patient orientated drug distribution named PAV (Patientenbezo-
gene Arzneimittel Versorgung). In 2004 nearly 1300 patients in
48 wards are served daily with the Unit Dose System. Every
patient’s medication proﬁle is recorded electronically. All medi-
cation orders are reviewed by pharmacists prior to delivering
medication. In this way continuing pharmaceutical consultation
is linked with the routine process of drug therapy. Medication
errors and resulting costs have been reduced, acceptance of
guidelines has been increased. On the base of ex-ante controll-
ing and pharmacoeconomic consultation decreasing of costs
should be reached. METHODS: On the base of the Problem-
Intervention-Documentation-System (PI-Doc) of Humbold Uni-
versity, Berlin the system was developed speciﬁcally for hospitals.
The goal was to analyse pharmaceutical interventions on med-
ication errors and the rational use of drugs. For a period of two
months all interventions were recorded by pharmacists.
RESULTS: In the 2 months of the study 3010 interventions were
recorded. A total of 2035 (67.6%) of the interventions are cat-
egorized as medication errors, including anamnesis and docu-
mentation errors and 975 (32.4%) of the recorded interventions
are associated with optimization of drug therapy and cost-effec-
tive use of drugs. In this category, the main part was the suc-
cessful adoption of the patients medication to the speciﬁc
formulary of the hospital (24.5% (738)). Decreasing the number
of special drug orders which are linked with extra process cost,
the saved direct cost has been calculated. CONCLUSIONS:
Pharmacists have a valuable role in preventing medication errors,
improve patient care and cost-effective use of drugs. The analy-
sis of pharmaceutical interventions highlights trends and patterns
in prescription and medication errors. These results are to be
used to improve effectiveness of pharmacists involvement in pre-
venting medication errors and economic outcomes.
PHP24
ANALYSIS OF “INNOVATOR” DRUGS FINANCED BY SPANISH
NATIONAL HEALTH SERVICE OVER THE PERIOD 1996–2003
Gaspar MD, Modamio P, Lastra CF, Mariño EL
University of Barcelona, Barcelona, Spain
OBJECTIVES: The Spanish National Health System (NHS) sys-
tematically introduces new and, obviously, higher-priced medi-
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cines in the public offer. Here, we analysed the impact of these
new medicines ﬁnanced by the Spanish NHS over the period
1996–2003, as a continuation of a previous one. METHODS: A
retrospective analysis has been made, selecting new medicines.
These have been classiﬁed following the degree of therapeutic
innovation at the moment of authorisation, according to two 
criteria, the Ministry of Health and Consume (MHC) and the
Drug Information Centre of Andalusia Autonomous Commu-
nity, (CADIME). Consume data were provided by the MHC
database and was expressed as Price for sale Direct to Customer,
tax-free (PDC), by means of millions of Euro (M€). The rapid
introduction of new medicines into the clinical practice (next to
one-hundred top) and the evolution of the consumption were 
the indicators used. RESULTS: The total number of new drugs
marketed during the period of the study was 113. From those,
20 are next to one-hundred top in the ﬁrst year after authorisa-
tion. None of them were categorised as “an exceptional thera-
peutic novelty”. Most were drugs with “non o very small
therapeutic improvement” or “insufﬁcient clinical evidence”
according to the MHC and CADIME classiﬁcation, respectively.
Different status of classiﬁcation was found in more than six of
the 20 new drugs. When analysing new drug consumption, it
detected that their quote is superior to 1.9%, in average, in rela-
tion to the public annual consumption. CONCLUSIONS: The
market size, devoted to recently introduced medicines with high
prices, is important. This is not in agreement with their limited
therapeutic innovation, being even least when CADIME classiﬁ-
cation is considered. Nevertheless, a notable decrease in the
number of “innovator” drugs introduced from the year 2001
was observed.
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WILLINGNESS TO PAY VERSUS OUT OF POCKET PAYMENTS
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OBJECTIVES: To compare willingness to pay (WTP) with out
of pocket (OoP) payments of the Greek population for primary
and secondary health services utilization. METHODS: A 
telephone survey was conducted in 2003, covering a national
random sample of 1000 participants questioned regarding their
additional WTP and OoP actual payments, for a 12 month
period, in order to improve their provision of health services in
terms of NHS responsiveness and access to health care.
RESULTS: A total of 95.6% respondents were compulsory
insured, 55.8% of WTP respondents were male, 53.8% of non
WTP female. Mean age of WTP respondents was 42.1 years. A
total of 63% urban residents, 13% semi-urban and 23.8% rural.
Twenty percent (20%) of those who declared WTP had an
income per month from 900 to 1500€, 14.7% from 501 to 900€,
20% from 1501 to 3000€ and the rest (37.8%) had an income
over 3001€. Of those who denied WTP, only 16.4% had spent
nothing as OoP payments for health services utilization during
the last year, 46.9% spent up to 150€, 14.2% spent from 151
to 300€, 8% from 301 to 600€, 6.4% from 600 to 1500€ and
2.3% over 1501€. According to the WTP amount already
declared, 62.8% of those willing to pay from 0 to 50€ had actu-
ally spent approximately a total of 150€ for health services uti-
lization during the last 12 months, while 100% of those willing
to pay from 601 to 900€ had only spent up 150€. CONCLU-
SIONS: A total of 70.8% of respondents declared non WTP for
improving their access and utilization of primary and hospital
care. Among the respondents who denied WTP, 83.6% declared
OoP actual payments starting from 150 to 1500€ per year. Our
ﬁndings may reﬂect the difference between revealed and stated
populations’ preferences.
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PHYSICIANS’ACTIVITY HETEROGENEITY: AN EMPIRICAL
STUDY IN TWO FRENCH REGIONS
Béjean S, Peyron C
University of Burgundy, Dijon, France
OBJECTIVES: The objective of the study was to identify differ-
ent GP’s practicing proﬁles, in order to better understand the way
French GP’s react to governmental measures to contain cost or
to increase quality of care. METHODS: We constructed a large
database about of 4700 GP’s from 2 French regions (Aquitaine
and Burgundy) for the year 2000. Variables described physicians’
volume and structure of medical activity (ofﬁce consultations,
home visits, medical procedures, prescriptions of pharmaceuti-
cal, lab tests and X-rays examinations), income level, personal
characteristics (age, gender, speciality, localisation, contractual
status with health insurance), practice characteristics (size, 
structure by age, percentage of hospitalised patients, etc.) and
socio-economic characteristics of the geographical environment
(physicians density, distance to the nearest hospital, unemploy-
ment rate, urban or rural town). The database was analysed
though a variety of statistical methods including cluster analysis
and econometric tests. RESULTS: Four different homogeneous
groups were identiﬁed, each of them relating physicians’ level of
activity to their socio-economic status. In group 1 for instance,
GP’s have a high level of activity (2340 patients and 9300 con-
sultations in average), 46% of them practice in rural areas and
only 4% are women. Conversely, physicians in group 4 have 
a low level of activity (1050 patients, 2400 consultations in
average), 75% are located in urban areas and 44% are women.
Econometric tests allow discriminating the main determinants of
multidimensional medical activity between rural and urban GP’s.
CONCLUSIONS: The way GP’s exert medicine is not uniform.
The level and the type of medical activity greatly vary among
physicians. Individual factors as well as characteristics of the
socio-economic environment greatly explain these differences.
An immediate consequence is that any cost-containment measure
which applies uniformly to all GP’s, such as regulating fees, 
necessarily results in different outcomes according to the type of
physicians’ category.
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AGE AND GENDER DISTRIBUTION OF PHARMACEUTICAL
EXPENDITURE PER INHABITANT
Gilabert-Perramon A, Magem-Luque D
Catalan Health Service, Barcelona, Spain
OBJECTIVES: To highlight the importance in establishing age
and gender bands with the aim of explaining the level of phar-
maceutical expenditure of each Primary Health Care Team
(PHCT). METHODS: Thanks to the advances of information
systems and the introduction of the Personal Health Card, it has
been possible to calculate the cost per inhabitant (according to
age and gender) taking into account the expense generated
through prescriptions produced by inhabitants assigned to the
Public Health System (Central Register of Insured). RESULTS:
According to some established criteria, 20 bands have been
determined. It is proved that 10% of the population is concen-
trated in the 67–77 year old band and the expenditure that it
generates is 33% of the total expense. However, the 9–12 year
old and 33–39 year old bands together (15% of the population)
only represent 3.8% of the total expense. Gender is also a rele-
vant variable. Women have a higher level of expense than men
for ages comprised between 21 and 72 and for those above 89
